6L

667, L.P.

DELAYED 1 MONTH

Director; Director, 10% Owner

ACADIA PHARMACEUTICALS INC
BeOne Medicines Ltd.
Denali Therapeutics Inc.
INCYTE CORP
Kiniksa Pharmaceuticals International, plc
Prelude Therapeutics Inc
TScan Therapeutics, Inc.

Filings

8

Companies

7

Latest

Jun 9, 2026

Transactions

Signal

Ticker / Company

Insider

Transaction

Value

Filed

—

BeOne Medicines Ltd.

667, L.P.

Director

Sale

$262.0K

10,998 sh

May 27 8:54 PM

May 22, 2026

—

INCYTE CORP

667, L.P.

Director, 10% Owner

Option Exercise

$2.5M

30,000 sh

May 11 8:45 PM

May 8, 2026